AIZ
82
2
IR
63
-3
LMT
30
-2
LEN
50
-2
PG
50
2
AMT
37
3
DHI
44
-3
EFX
30
-8
UNH
57
-2
MLM
45
-5
PPG
57
-3
CAG
24
-3
ILMN
32
-9
NWSA
62
-7
NVDA
52
-5
F
56
-3
PBI
56
-2
EQT
51
-3
HRB
59
2
PEP
39
-9
AIZ
82
2
IR
63
-3
LMT
30
-2
LEN
50
-2
PG
50
2
AMT
37
3
DHI
44
-3
EFX
30
-8
UNH
57
-2
MLM
45
-5
PPG
57
-3
CAG
24
-3
ILMN
32
-9
NWSA
62
-7
NVDA
52
-5
F
56
-3
PBI
56
-2
EQT
51
-3
HRB
59
2
PEP
39
-9
Financhill
Back

Invesco ESG NASDAQ 100 ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
67

QQMG
Invesco ESG NASDAQ 100 ETF

Last Price:
34.02
Seasonality Move:
2.76%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
67
Invesco ESG NASDAQ 100 ETF (QQMG) is a Buy

Is Invesco ESG NASDAQ 100 ETF a Buy, Sell or Hold?

  • The current Invesco ESG NASDAQ 100 ETF [QQMG] share price is $33.97. The Score for QQMG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • QQMG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QQMG Stock Price Chart

What is Invesco ESG NASDAQ 100 ETF's stock price today?

  • The Invesco ESG NASDAQ 100 ETF share price today is $33.97
    The current trend is moderately bearish and QQMG is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

QQMG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.35 Buy
Relative Strength Index (14 RSI): 47.89 Sell
Chaikin Money Flow: -5402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.53 - 34.77) Sell
Bollinger Bands (100): (31.9 - 34.24) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

QQMG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.9 Sell
20-day SMA: 34.23 Sell
50-day SMA: 33.56 Buy
200-day SMA: 31.78 Buy
8-day EMA: 34.6 Sell
20-day EMA: 34.3 Sell
50-day EMA: 33.71 Buy
200-day EMA: 31.58 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Invesco ESG NASDAQ 100 ETF Earnings Growth & QQMG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Invesco ESG NASDAQ 100 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):